Antiarrythmic 1-arylcarbamoylalkyl-2-imidazoline derivatives, composition and method of use
US4353921A · kind A · utility
3Cited by
3References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 19, 1981 |
| Grant date | Oct 12, 1982 |
| Priority date | — |
| Expiry date | Jun 19, 2001 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D249/08
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel 1,2-disubstituted imidazol(in)es are described herein. The compounds are generally produced by reacting a haloacylanilide with an excess of 2-substituted-imidazol(in)e. The compounds are antiarrhythmic agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.